Actinium Pharmaceuticals, Inc.
ATNM· NYSE
ATNMActinium Pharmaceuticals, Inc.
Filed May 12, 2014 · 10-Q · 42 days after period end · 0001213900-14-003153
| Metric | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|
| Revenue | — | — | $0.00 |
| Net Income | -$16.70M | -$689.03K | -$908.91K |
| EPS Diluted | -$0.66 | -$0.03 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Actinium Pharmaceuticals, Inc. · CIK 1388320 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end
